These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 20508576)

  • 1. [Diffusion-weighted MR imaging of the prostate].
    Cornud F; Liberatore M; Beuvon F; Barry N
    J Radiol; 2010 Mar; 91(3 Pt 2):421-8; quiz 429-30. PubMed ID: 20508576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of dynamic MR imaging for hypointensity lesions of the peripheral zone of the prostate.
    Namimoto T; Morishita S; Saitoh R; Kudoh J; Yamashita Y; Takahashi M
    Comput Med Imaging Graph; 1998; 22(3):239-45. PubMed ID: 9740041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gadolinium-DOTA enhanced MR imaging of prostatic lesions. Preliminary results on 14 cases.
    Gevenois PA; Sintzoff SA; Stallenberg B; Salmon I; Simon J; Van Regemorter G; Struyven J
    J Belge Radiol; 1992 Feb; 75(1):5-10. PubMed ID: 1373715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
    Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
    Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate cancer: relationships between postbiopsy hemorrhage and tumor detectability at MR diagnosis.
    Tamada T; Sone T; Jo Y; Yamamoto A; Yamashita T; Egashira N; Imai S; Fukunaga M
    Radiology; 2008 Aug; 248(2):531-9. PubMed ID: 18539890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Temporal Resolution on Diagnostic Performance of Dynamic Contrast-Enhanced Magnetic Resonance Imaging of the Prostate.
    Othman AE; Falkner F; Weiss J; Kruck S; Grimm R; Martirosian P; Nikolaou K; Notohamiprodjo M
    Invest Radiol; 2016 May; 51(5):290-6. PubMed ID: 26619282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detecting prostate cancer and prostatic calcifications using advanced magnetic resonance imaging.
    Dou S; Bai Y; Shandil A; Ding D; Shi D; Haacke EM; Wang M
    Asian J Androl; 2017; 19(4):439-443. PubMed ID: 27004542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation of central gland prostate cancer from benign prostatic hyperplasia using monoexponential and biexponential diffusion-weighted imaging.
    Liu X; Zhou L; Peng W; Wang C; Wang H
    Magn Reson Imaging; 2013 Oct; 31(8):1318-24. PubMed ID: 23791546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffusion and perfusion MR imaging of the prostate.
    Somford DM; Fütterer JJ; Hambrock T; Barentsz JO
    Magn Reson Imaging Clin N Am; 2008 Nov; 16(4):685-95, ix. PubMed ID: 18926431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prostatic pathology imaged by magnetic resonance. 58 cases].
    Gevenois PA; Van Regemorter G; Van Gansbeke D; Delcour C; Corbusier A; Struyven J
    J Radiol; 1987 Mar; 68(3):185-92. PubMed ID: 2439686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative diffusion-weighted imaging and dynamic contrast-enhanced characterization of the index lesion with multiparametric MRI in prostate cancer patients.
    Yuan Q; Costa DN; Sénégas J; Xi Y; Wiethoff AJ; Rofsky NM; Roehrborn C; Lenkinski RE; Pedrosa I
    J Magn Reson Imaging; 2017 Mar; 45(3):908-916. PubMed ID: 27442039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3T multiparametric MRI of the prostate: Does intravoxel incoherent motion diffusion imaging have a role in the detection and stratification of prostate cancer in the peripheral zone?
    Valerio M; Zini C; Fierro D; Giura F; Colarieti A; Giuliani A; Laghi A; Catalano C; Panebianco V
    Eur J Radiol; 2016 Apr; 85(4):790-4. PubMed ID: 26971425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MR imaging of the prostate: 1.5T versus 3T.
    Cornfeld DM; Weinreb JC
    Magn Reson Imaging Clin N Am; 2007 Aug; 15(3):433-48, viii. PubMed ID: 17893061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic contrast-enhanced MRI of prostate cancer at 3 T: a study of pharmacokinetic parameters.
    Ocak I; Bernardo M; Metzger G; Barrett T; Pinto P; Albert PS; Choyke PL
    AJR Am J Roentgenol; 2007 Oct; 189(4):849. PubMed ID: 17885055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiparametric MRI in detection and staging of prostate cancer.
    Boesen L
    Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of Parotid Tumors With Dynamic Susceptibility Contrast Perfusion-Weighted Magnetic Resonance Imaging and Diffusion-Weighted MR Imaging.
    Abdel Razek AA; Samir S; Ashmalla GA
    J Comput Assist Tomogr; 2017 Jan; 41(1):131-136. PubMed ID: 27636248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benign prostatic hyperplasia: evaluation of T1, T2, and microvascular characteristics with T1-weighted dynamic contrast-enhanced MRI.
    Kershaw LE; Hutchinson CE; Buckley DL
    J Magn Reson Imaging; 2009 Mar; 29(3):641-8. PubMed ID: 19243046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation of transitional zone prostate cancer from benign hyperplasia nodules: evaluation of discriminant criteria at multiparametric MRI.
    Chesnais AL; Niaf E; Bratan F; Mège-Lechevallier F; Roche S; Rabilloud M; Colombel M; Rouvière O
    Clin Radiol; 2013 Jun; 68(6):e323-30. PubMed ID: 23528164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic accuracy of biparametric vs multiparametric MRI in clinically significant prostate cancer: Comparison between readers with different experience.
    Di Campli E; Delli Pizzi A; Seccia B; Cianci R; d'Annibale M; Colasante A; Cinalli S; Castellan P; Navarra R; Iantorno R; Gabrielli D; Buffone A; Caulo M; Basilico R
    Eur J Radiol; 2018 Apr; 101():17-23. PubMed ID: 29571792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T(2)-weighted combined with diffusion-weighted images for evaluating prostatic transition zone tumors at 3 Tesla.
    Ren J; Yang Y; Zhang J; Xu J; Liu Y; Wei M; Ge Y; Huan Y; Larson AC; Zhang Z
    Future Oncol; 2013 Apr; 9(4):585-93. PubMed ID: 23560380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.